178 related articles for article (PubMed ID: 29306436)
1. Activity-Based Probes for Glycosidases: Profiling and Other Applications.
Kuo CL; van Meel E; Kytidou K; Kallemeijn WW; Witte M; Overkleeft HS; Artola ME; Aerts JM
Methods Enzymol; 2018; 598():217-235. PubMed ID: 29306436
[TBL] [Abstract][Full Text] [Related]
2. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
[TBL] [Abstract][Full Text] [Related]
3. Xylose-Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase.
Su Q; Schröder SP; Lelieveld LT; Ferraz MJ; Verhoek M; Boot RG; Overkleeft HS; Aerts JMFG; Artola M; Kuo CL
Chembiochem; 2021 Nov; 22(21):3090-3098. PubMed ID: 34459538
[TBL] [Abstract][Full Text] [Related]
4. Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes.
Herrera Moro Chao D; Kallemeijn WW; Marques AR; Orre M; Ottenhoff R; van Roomen C; Foppen E; Renner MC; Moeton M; van Eijk M; Boot RG; Kamphuis W; Hol EM; Aten J; Overkleeft HS; Kalsbeek A; Aerts JM
PLoS One; 2015; 10(9):e0138107. PubMed ID: 26418157
[TBL] [Abstract][Full Text] [Related]
5. Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish.
Artola M; Kuo CL; Lelieveld LT; Rowland RJ; van der Marel GA; Codée JDC; Boot RG; Davies GJ; Aerts JMFG; Overkleeft HS
J Am Chem Soc; 2019 Mar; 141(10):4214-4218. PubMed ID: 30811188
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive in situ visualization of active glucocerebrosidase molecules.
Witte MD; Kallemeijn WW; Aten J; Li KY; Strijland A; Donker-Koopman WE; van den Nieuwendijk AM; Bleijlevens B; Kramer G; Florea BI; Hooibrink B; Hollak CE; Ottenhoff R; Boot RG; van der Marel GA; Overkleeft HS; Aerts JM
Nat Chem Biol; 2010 Dec; 6(12):907-13. PubMed ID: 21079602
[TBL] [Abstract][Full Text] [Related]
7. In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labeling.
van Smeden J; Dijkhoff IM; Helder RWJ; Al-Khakany H; Boer DEC; Schreuder A; Kallemeijn WW; Absalah S; Overkleeft HS; Aerts JMFG; Bouwstra JA
J Lipid Res; 2017 Dec; 58(12):2299-2309. PubMed ID: 29025868
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of Glucocerebrosidase by Active Site Occupancy.
Ben Bdira F; Kallemeijn WW; Oussoren SV; Scheij S; Bleijlevens B; Florea BI; van Roomen CPAA; Ottenhoff R; van Kooten MJFM; Walvoort MTC; Witte MD; Boot RG; Ubbink M; Overkleeft HS; Aerts JMFG
ACS Chem Biol; 2017 Jul; 12(7):1830-1841. PubMed ID: 28485919
[TBL] [Abstract][Full Text] [Related]
9. Localization of active endogenous and exogenous β-glucocerebrosidase by correlative light-electron microscopy in human fibroblasts.
van Meel E; Bos E; van der Lienden MJC; Overkleeft HS; van Kasteren SI; Koster AJ; Aerts JMFG
Traffic; 2019 May; 20(5):346-356. PubMed ID: 30895685
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-Quenched Substrates for Quantitative Live Cell Imaging of Glucocerebrosidase Activity.
Ashmus RA; Shen DL; Vocadlo DJ
Methods Enzymol; 2018; 598():199-215. PubMed ID: 29306435
[TBL] [Abstract][Full Text] [Related]
11. A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid/base residues in human retaining β-glucosidases.
Kallemeijn WW; Witte MD; Voorn-Brouwer TM; Walvoort MT; Li KY; Codée JD; van der Marel GA; Boot RG; Overkleeft HS; Aerts JM
J Biol Chem; 2014 Dec; 289(51):35351-62. PubMed ID: 25344605
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic Interactions Contribute to Conformational Stabilization of Endoglycoceramidase II by Mechanism-Based Probes.
Ben Bdira F; Jiang J; Kallemeijn W; de Haan A; Florea BI; Bleijlevens B; Boot R; Overkleeft HS; Aerts JM; Ubbink M
Biochemistry; 2016 Aug; 55(34):4823-35. PubMed ID: 27455091
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibitors of glycosidases: design and applications.
Kallemeijn WW; Witte MD; Wennekes T; Aerts JM
Adv Carbohydr Chem Biochem; 2014; 71():297-338. PubMed ID: 25480507
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents.
Rowland RJ; Chen Y; Breen I; Wu L; Offen WA; Beenakker TJ; Su Q; van den Nieuwendijk AMCH; Aerts JMFG; Artola M; Overkleeft HS; Davies GJ
Chemistry; 2021 Nov; 27(66):16377-16388. PubMed ID: 34570911
[TBL] [Abstract][Full Text] [Related]
15. Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors.
Li KY; Jiang J; Witte MD; Kallemeijn WW; Donker-Koopman WE; Boot RG; Aerts JM; Codée JD; van der Marel GA; Overkleeft HS
Org Biomol Chem; 2014 Oct; 12(39):7786-91. PubMed ID: 25156485
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
Trapero A; Llebaria A
Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
[TBL] [Abstract][Full Text] [Related]
17. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
18. Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.
Kallemeijn WW; Scheij S; Hoogendoorn S; Witte MD; Herrera Moro Chao D; van Roomen CP; Ottenhoff R; Overkleeft HS; Boot RG; Aerts JM
PLoS One; 2017; 12(2):e0170268. PubMed ID: 28207759
[TBL] [Abstract][Full Text] [Related]
19. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
20. New Irreversible α-l-Iduronidase Inhibitors and Activity-Based Probes.
Artola M; Kuo CL; McMahon SA; Oehler V; Hansen T; van der Lienden M; He X; van den Elst H; Florea BI; Kermode AR; van der Marel GA; Gloster TM; Codée JDC; Overkleeft HS; Aerts JMFG
Chemistry; 2018 Dec; 24(71):19081-19088. PubMed ID: 30307091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
